期刊文献+

人白细胞介素-10/人肝再生增强因子融合基因的构建及在肝细胞中的表达 被引量:2

Construction of human interleukin-10/augmenter of regeneration fused gene and its expression in hepa-tocyte
原文传递
导出
摘要 目的 利用人自细胞介索(IL)-10和肝再生增强因子(ALP)构建融合基因hIL-10/ALR和真核表达载体,验证其在肝细胞中的表达。方法 以富含疏水氨基酸(Gly-Ser)n的相应寡核苷酸接头序列为媒介,通过hIL-10和hALR克隆载体构建真核质粒表达载体pcDNA3hIL-10/ALR,纯化后转染L02肝细胞,并以逆转录-聚合酶链反应(RT-PCR)方法检测其表达。结果 成功构建hIL-10/ALR融合基因,其真核表达载体pcDNA3hIL-10/ALR可在L02肝细胞中有效表达。结论通过融合基因转导方法可能实现IL-10和ALR的各自功能,为肝纤维化、肝硬变的基因治疗探索有效手段。 Objective To construct the human interleukin-10/augmenter of regeneration fused gene and its eukaryotic expression plasmid vector and demonstrate its expression in L02 hepatocyte. Methods The human interleukin-10 gene and human augmenter of regeneration gene were ligated with a specially designed oligonucleotide, whose corresponding amino acid sequence was rich of hydrophobic amino acid residues (Gly-Ser)n. L02 hepatocytes were transfected with the fused gene plasmid vector, and its expression was detected by RT-PCR. Results The hIL-10/ALR fused gene was successfully constructed and could be effectively expressed in L02 hepatocytes. Conclusion The hIL-10 and hALR gene may realize to show their corresponsive function with the fused gene transduction, and set up an effective approach to exploration of gene therapy of liver fibrosis and cirrhosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2004年第9期1051-1052,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30070739 30300340) 黑龙江省自然科学基金资助项目(D0104)
关键词 ALR 肝细胞 融合基因 IL-10 真核表达载体 肝再生增强因子 白细胞介素-10 PCDNA3 真核 克隆载体 <Keyword>terleukin 10 Gene expression Liver cirrhosis
  • 相关文献

参考文献4

  • 1Thompson K,Maltby J,Fallowfield J,et al.Interleukin-10 expression and function inexperimental murine liver inflammation and fibrosis.Hepatology,1998,28:1597-1606.
  • 2Louis H,Var Laethem JL,Wu W,et al.Interlenkin-10 controls neutrophilic infiltration,hepatocyte proliferation,and liver fibrosis induced by carbon tetrachloride in mice.Hepatology,1998,28:1607-1615.
  • 3Thompson KC,Trowern A,Fowell A,et al.Primary rat and mouce hepatic stellate cells express the macrophage inhibitor cytokine interlenkin-10 during the course of activation in vitro.Hepatology,1998,28:1518-1524.
  • 4Dai WJ,Jiang HC.Advances in gene therapy of liver cirrhosis.World J Gastroenterology,2001,7:1-8.

同被引文献13

  • 1陈谦学,邵步云,郑虎,吴立权,黄乔春,叶应湖.转化生长因子β1及其信号转导分子Smad4,Smad7在人脑胶质瘤中的表达及其意义[J].中华实验外科杂志,2005,22(1):90-92. 被引量:16
  • 2刘辰,吴孟超,张柏和,郝立,王星华,刘懿萱,崔贞福,钱其军.静脉注射携带人白介素-10的腺病毒载体对肝硬化大鼠肝缺血再灌注损伤的保护作用[J].中华肝胆外科杂志,2005,11(12):836-839. 被引量:3
  • 3姜海平,袁璐,张海伟,张文斌.肝脏纤维化中天冬氨酸特异性半胱氨酸蛋白酶-3的表达[J].中华实验外科杂志,2007,24(5):546-547. 被引量:3
  • 4Miyazono K, Maeda S, Imamura T. Coordinate regulation of cell growth and differentiation by TGF-β superfamily and runx proteins. Oncogene,2004,23 : 4232-4237.
  • 5Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8^+ T cells to the spleen during tb, e generation of regulatory T cells in tolerance. J Immunol,2002 ,169 :31-38.
  • 6Adler EP, Lemken CA, Katehen NS, et al. A dual role for tumor-derived chemokine RANTES ( CCL5 ). Immunol Lett, 2003,90 : 187-194.
  • 7Nattermann J, Nischalke HD, Feldmann G, et al. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat ,2004,11:519-526.
  • 8Marcos LA,Terashima A,Yi P, ct al. Mechanisms of liver fibrosis as- sociated with experimental Faseiola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell activation [ J ]. J Parasitol,2011, 97 ( 1 ) : 82-87.
  • 9Zhang LJ,Zheng WD, Chen YX, et al. Antifibrotic effects of interleu- kin-10 on experimental hepatic fibrosis [ J ]. Hepatogastroenterology, 2007,54 ( 79 ) :2092-2098.
  • 10Ji JD,Tassiulas I, Park-Min KH,et al. Inhibition of interleukin 10 sig- naling after Fc receptor ligation and during rheumatoid arthritis [ J ]. J Exp Med ,2003,197 ( 11 ) : 1573-1583.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部